WASHINGTON – Drugmaker MSN Pharmaceuticals cleared another hurdle on Thursday toward launching its generic version of Novartis’ (NYSE: NVS) blockbuster […]
US Appeals Court Lifts Pause on Generic Version of Novartis’ Entresto Read More »
COPENHAGEN – Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby
Novo Nordisk, Other Firms Meet Danish Prime Minister to Discuss Trump Tariff Threats Read More »
On Thursday, UnitedHealth Group (NYSE: UNH) CEO Andrew Witty said that healthcare in the U.S. needs to be “less confusing,
UnitedHealth Group CEO Says Complex US Healthcare System Needs to Change Read More »
WASHINGTON – A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals’ launch of a generic version of Novartis’ (NYSE: NVS)
Novartis Wins Temporary Pause to Entresto Generic Launch in US Read More »
Gilead Sciences (NASDAQ: GILD) and the U.S. government have settled a billion-dollar patent dispute over Gilead’s HIV prevention drugs Truvada
Gilead Sciences, US Government Settle Patent Case Over HIV Prevention Drugs Read More »
Analysts and investors are awaiting details behind UnitedHealth Group’s (NYSE: UNH) 2025 outlook when it reports quarterly results on Thursday
UnitedHealth Investors Await Details Behind 2025 Outlook After Exec’s Murder Read More »
WASHINGTON – The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for
US FTC Finds Major Pharmacy Benefit Managers Inflated Drug Prices for $7.3 Billion Gain Read More »
Pfizer (NYSE: PFE) will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon (NYSE: HLN), lowering its stake in
Pfizer to Sell $3 Billion Stake in Sensodyne Maker Haleon Read More »
On Tuesday, the U.S. Food and Drug Administration proposed that food companies display nutrition labels on the front of the
FDA Proposes Putting Nutrition Labels on the Front of Packaged Foods in Health Push Read More »
Copyright © 2025 abbonews.com
